Erin DiGirolamo

Freelance medical writer | MPH | Published: @Medscape @OncologyTimes | #HealthCommunications #PublicHealth #HealthLiteracy

[Erin DiGirolamo @DigirolamoErin8]

Are Drug‑Resistant Infections Outpacing Industry Efforts? https://t.co/bCG1HKezJ4 @Medscape

[The Wall Street Journal @WSJ]

There’s a quiet revolution rewriting the rules of Type-A motherhood. 🔗 https://t.co/LI3bMXFsfQ

[Oncology Times @OncologyTimes]

#Cannabis use is common among adults with #cancer, and new #ASCO guidelines urge clinicians to discuss it openly, provide evidence‑based education, caution against its use as a cancer treatment, and guide patients on potential risks. https://t.co/GOiPBzhoWs

[Oncology Times @OncologyTimes]

Learn how #EarlyMenopause from #EndocrineTherapy can impact young #BreastCancer survivors—and what steps can help protect your long‑term health. Read more: https://t.co/xtEsgemvlw

[Oncology Times @OncologyTimes]

At @MDAndersonNews, neuro-oncology researchers are working to better balance the risk-benefit ratio of cancer therapy and neurotoxicity, so patients can successfully continue treatment. https://t.co/YOGlcksw28 #CancerResearch #Oncology #NeuroOncology

[Oncology Times @OncologyTimes]

New treatments are helping #YoungSurvivors with hormone receptor–positive #BreastCancer live longer. However, #EndocrineTherapy can trigger #EarlyMenopause and understanding what to expect is key to protecting quality of life. https://t.co/uXhkXArykX

[Oncology Times @OncologyTimes]

New treatments are helping young survivors with hormone receptor–positive #BreastCancer live longer. However, endocrine therapy can trigger early menopause and understanding what to expect is key to protecting quality of life. https://t.co/TDUvhSCNa0

[Oncology Times @OncologyTimes]

At @MDAndersonNews, neuro-oncology researchers are working to better balance the risk-benefit ratio of cancer therapy and neurotoxicity, so patients can successfully continue treatment. https://t.co/pkrmhMKI4X #CancerResearch #Oncology #NeuroOncology

[Erin DiGirolamo @DigirolamoErin8]

As today marks #WorldCancerDay, kudos to the NeuroHealth Initiative at MD Anderson Cancer Center for detangling the interplay between cancer and the nervous system. Read more in @OncologyTimes
https://t.co/ybP8kZ6RwQ

[Oncology Times @OncologyTimes]

The February issue is out now! It features Stagnant U.S. #CervicalCancer Rates Raise Concerns About #Screening, Parents & Clinicians Diverge on Psychosocial Priorities in #PediatricOncology, and more. Read it here: https://t.co/4QH8XnzkFC

[Erin DiGirolamo @DigirolamoErin8]

Hey young #breastcancer survivors (with HR+ disease): Here's how you can manage early menopause with key questions to ask your provider! Check out this #patienteducation resource published in @OncologyTimes

https://t.co/kUseWNE1tA

[Erin DiGirolamo @DigirolamoErin8]

In an era when so many view AI as a tool, virologists are sizing it up to potentially predict the next pandemic. AI shows potential in helping global health experts detect emerging infectious diseases earlier. https://t.co/ji1nQDA0Pk

[Erin DiGirolamo @DigirolamoErin8]

D-Dimer Alone May Miss Thromboembolism in Pregnancy https://t.co/k40aRh5cRm

[Erin DiGirolamo @DigirolamoErin8]

AI Model May Help Predict Pediatric Sepsis Before Organ Dysfunction https://t.co/S9E96jPw9T

[Oncology Times @OncologyTimes]

#MultipleMyeloma remains a complex malignancy of the bone marrow that is preceded by monoclonal gammopathy of undetermined significance or smoldering multiple myeloma. A new #bloodtest may change treatment: https://t.co/XJQewwCRMk

[Oncology Times @OncologyTimes]

Researchers designed and evaluated the impact of the patient-reported outcomes system, which enables patients to regularly report their symptoms and side effects to their #OncologyCare team through a web-based platform or automated telephone line. https://t.co/NXC27ujhaE

[Oncology Times @OncologyTimes]

To address the hurdles of #survivorship, the #breastcancer survivorship program at Memorial Sloan Kettering delivers comprehensive care starting 2 years after the completion of acute treatment. Read more: https://t.co/IFTBp2CLnv #BreastCancerAwarenessMonth

[Oncology Times @OncologyTimes]

Patients living with #metastatic disease may benefit from a safety-net system designed to catch emergency health issues at home, according to a new study from the University of North Carolina Lineberger Comprehensive Cancer Center. https://t.co/yqSVcTMpM8

[Oncology Times @OncologyTimes]

The connection between #gutmicrobiome health and #immunotherapy efficacy is drawing increasing interest in oncology. At the #ASCO25, experts reinforced the link between gut dysbiosis and diminished response to immunotherapy. https://t.co/YSfa3oJGbC

[Oncology Times @OncologyTimes]

“#Survivorship care for #breastcancer patients is important because, in addition to fear and anxiety, there are many long-term side effects of breast cancer treatments,” said Adriana Olivo, MSN, RN. Read more: https://t.co/JRZEvv9piG #BreastCancerAwarenessMonth